155
Views
2
CrossRef citations to date
0
Altmetric
CHEMICAL PATHOLOGY

Steroid‐induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy

, , , , , , , , , , , & show all
Pages 229-235 | Received 05 Aug 2005, Accepted 07 Feb 2006, Published online: 06 Jul 2009

References

  • Biffl W. L., Moore F. A., Moore E. E., Haenel J. B., McIntyre R. C Jr., Burch J. M. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome?. Am J Surg 1995; 170: 591–5
  • Harris M., Hauser S., Nguyen T. V., et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 2001; 37: 67–71
  • Felson D. T., Anderson J. J. Across‐study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1987; 1: 902–6
  • Ono K., Tohjima T., Komazawa T. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high‐dose corticosteroid therapy. Clin Orthop 1992; 277: 89–97
  • Lee N., Hui D., Wu A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–94
  • Wong C. K., Lam C. W. K., Wu A. K. L., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136: 95–103
  • Chan M. H. M., Wong V. W. S., Wong C. K., et al. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome (SARS). J Intern Med 2004; 255: 512–8
  • Thompson B. T. Glucocorticoids and acute lung injury. Crit Care Med 2003; 31: S253–7
  • Panesar N. S. Lymphopenia in SARS. Lancet 2003; 361: 1985
  • Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003; 348: 2034–5
  • World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/casedefinition/en/print.html (accessed February 2006)
  • World Health Organization. PCR primers for SARS developed by WHO Network Laboratories. http://www.who.int/csr/sars/primers/en/print.html (accessed February 2006)
  • Wong G. W. K., Hui D. S. C. Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax 2003; 58: 558–60
  • McEvoy G. K. American Hospital Formulary Service Drug Information. American Society of Hospital Pharmacists, Bethesda 2002; 2748
  • Mankin H. J. Non‐traumatic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326: 1473–9
  • Mulliken B. D., Renfrew D. L., Brand R. A., Whitten C. G. Prevalence of previously undetected osteonecrosis of the femoral head in renal transplant recipients. Radiology 1994; 192: 831
  • Migliaresi S., Picillo U., Ambrosone L., et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37–41
  • Risteli L., Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25: 385–93
  • Koo K. H., Kim R., Kim Y. S., et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 2002; 21: 299–303
  • Griffith J. F., Antonio G. E., Kumta S. M., et al. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 2005; 235: 168–75
  • Soo Y. O., Cheng Y., Wong R., et al. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004; 10: 676–8
  • Oven T. A., Aronow M., Shalhoub V., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420–30
  • Pocock N. A., Eisman J. A., Dunstan C. R., Evans R. A., Thomas D. H., Huq N. L. Recovery from steroid‐induced osteoporosis. Ann Intern Med 1987; 107: 319–23
  • Christenson R. H. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997; 30: 573–93
  • Fottrell P. F., Power M. J. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991; 28: 287–335
  • Cohn D. V., Martin T. J., Meunier P. J. Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects, , et al. Elsevier, Amsterdam 1981; 419–26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.